The move allows Mars’ Science & Diagnostics division to expand its European footprint.
Munich-based provider of laboratory diagnostic services SYNLAB has agreed to sell its veterinary business to Mars.
SYNLAB Vet will join the portfolio of Mars Petcare, integrating their services across veterinary health and diagnostics, nutrition, innovation, and technology.
Nefertiti Greene, President at Mars Science & Diagnostics, says that the transaction complements their existing diagnostics business and believes it will bring additional reach across the European region.
SYNLAB, which did not reveal the value of the deal, has allegedly decided to sell the business to Mars to refocus on its core human diagnostic operations.
According to some sources, the firm’s veterinary diagnostics unit generated only 1% of the group’s total €3.2 billion ($3.4B) revenue in 2022.
SYNLAB operates across 40 countries over 4 continents, primarily boasting a strong network in Europe.
The latest articles
European pet food manufacturers establish new group
SANYpet, Natural Line and Codico have created a new production and distribution group to capture the international market.
Flybird Holding’s tender offer for Musti is expected to be completed by March
Portuguese group Sonae increased the amount that shareholders of the Nordic pet retailer will obtain to €26.10 per share.
Zoetis increased revenue by 6% in 2023
Sales of its osteoarthritis, flea, tick and heartworm medications have driven the company’s pet portfolio’s positive results in the last quarter of 2023.
Weekly newsletter to stay up-to-date
Discover what’s happening in the pet industry. Get the must-read stories and insights in your inbox.